These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9300608)

  • 1. D1 agonist dihydrexidine releases acetylcholine and improves cognitive performance in rats.
    Steele TD; Hodges DB; Levesque TR; Locke KW
    Pharmacol Biochem Behav; 1997 Oct; 58(2):477-83. PubMed ID: 9300608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The D1 agonist dihydrexidine releases acetylcholine and improves cognition in rats.
    Steele TD; Hodges DB; Levesque TR; Locke KW; Sandage BW
    Ann N Y Acad Sci; 1996 Jan; 777():427-30. PubMed ID: 8624125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dihydrexidine, a full dopamine D-1 receptor agonist, on delayed response performance in chronic low dose MPTP-treated monkeys.
    Schneider JS; Sun ZQ; Roeltgen DP
    Brain Res; 1994 Nov; 663(1):140-4. PubMed ID: 7850462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerance to the procholinergic action of the D1 receptor full agonist dihydrexidine.
    Wade MR; Nomikos GG
    Psychopharmacology (Berl); 2005 Nov; 182(3):393-9. PubMed ID: 16075289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 68930 and dihydrexidine inhibit locomotor activity and d-amphetamine-induced hyperactivity in rats: a role of inhibitory dopamine D(1/5) receptors in the prefrontal cortex?
    Isacson R; Kull B; Wahlestedt C; Salmi P
    Neuroscience; 2004; 124(1):33-42. PubMed ID: 14960337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single 20 mg dose of the full D1 dopamine agonist dihydrexidine (DAR-0100) increases prefrontal perfusion in schizophrenia.
    Mu Q; Johnson K; Morgan PS; Grenesko EL; Molnar CE; Anderson B; Nahas Z; Kozel FA; Kose S; Knable M; Fernandes P; Nichols DE; Mailman RB; George MS
    Schizophr Res; 2007 Aug; 94(1-3):332-41. PubMed ID: 17596915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydrexidine produces hypothermia in rats via activation of dopamine D1 receptors.
    Salmi P; Ahlenius S
    Neurosci Lett; 1997 Oct; 236(1):57-9. PubMed ID: 9404951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine D1 receptors: efficacy of full (dihydrexidine) vs. partial (SKF38393) agonists in primates vs. rodents.
    Watts VJ; Lawler CP; Gilmore JH; Southerland SB; Nichols DE; Mailman RB
    Eur J Pharmacol; 1993 Sep; 242(2):165-72. PubMed ID: 7902811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The discriminative properties of the D1 dopamine agonist dihydrexidine in the rat.
    Schechter MD
    Psychopharmacology (Berl); 1995 May; 119(1):79-84. PubMed ID: 7675953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral effects in the rat of dihydrexidine, a high-potency, full-efficacy D1 dopamine receptor agonist.
    Darney KJ; Lewis MH; Brewster WK; Nichols DE; Mailman RB
    Neuropsychopharmacology; 1991 Nov; 5(3):187-95. PubMed ID: 1684499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydrexidine--the first full dopamine D1 receptor agonist.
    Salmi P; Isacson R; Kull B
    CNS Drug Rev; 2004; 10(3):230-42. PubMed ID: 15492773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dopamine D1 receptor agonists in rats trained to discriminate dihydrexidine.
    Gleason SD; Witkin JM
    Psychopharmacology (Berl); 2006 May; 186(1):25-31. PubMed ID: 16575553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychopharmacological distinction between novel full-efficacy "D1-like" dopamine receptor agonists.
    Deveney AM; Waddington JL
    Pharmacol Biochem Behav; 1997 Oct; 58(2):551-8. PubMed ID: 9300618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple dopamine receptors mediate the discriminative stimulus effects of dihydrexidine in rats.
    Gleason SD; Yin T; Little SP; Delapp N; Witkin JM
    Behav Pharmacol; 2011 Sep; 22(5-6):531-9. PubMed ID: 21836463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
    Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydrexidine, a full D1 dopamine receptor agonist, induces rotational asymmetry in hemiparkinsonian monkeys.
    Johnson BJ; Peacock V; Schneider JS
    Pharmacol Biochem Behav; 1995 Aug; 51(4):617-22. PubMed ID: 7675833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCH 57790, a selective muscarinic M(2) receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animals.
    Carey GJ; Billard W; Binch H; Cohen-Williams M; Crosby G; Grzelak M; Guzik H; Kozlowski JA; Lowe DB; Pond AJ; Tedesco RP; Watkins RW; Coffin VL
    Eur J Pharmacol; 2001 Nov; 431(2):189-200. PubMed ID: 11728425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the D₁ dopamine full agonists, dihydrexidine and doxanthrine, in the 6-OHDA rat model of Parkinson's disease.
    McCorvy JD; Watts VJ; Nichols DE
    Psychopharmacology (Berl); 2012 Jul; 222(1):81-7. PubMed ID: 22222862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potent and selective dopamine D1 receptor agonist A-77636 increases cortical and hippocampal acetylcholine release in the rat.
    Acquas E; Day JC; Fibiger HC
    Eur J Pharmacol; 1994 Jul; 260(1):85-7. PubMed ID: 7957630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective dopamine D4 receptor agonist (A-412997) improves cognitive performance and stimulates motor activity without influencing reward-related behaviour in rat.
    Woolley ML; Waters KA; Reavill C; Bull S; Lacroix LP; Martyn AJ; Hutcheson DM; Valerio E; Bate S; Jones DN; Dawson LA
    Behav Pharmacol; 2008 Dec; 19(8):765-76. PubMed ID: 19020411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.